07-05-2013

Scientists in India report the functionalisation of TiO2 nanoparticles with two different biomolecules – tris-(nitrilo tris-acetic acid) and biotin. The biocompatible nanoparticles is non-cytotoxic and can deliver multiple biomolecules into the cell. In the future the nanoparticles could act ...

more

05-03-2013

Carbon-based nanomaterials have been found to enhance the ability of the anti-cancer drug Paclitaxel to treat of lung cancer. Both graphene oxide and single-walled carbon nanotubes were found to enhance cancer-cell death in lung-cancer cells when combined with the Paclitaxel, indicating a ...

more

First fully automated production line for pharmaceutical packaging sets new standards in India

11-02-2013

With the opening of a high-tech facility in India, SCHOTT continues to strengthen its strategic position in the Asian pharmaceutical market. As with the existing production plant in the city of Daman, SCHOTT KAISHA, a joint venture in which SCHOTT holds a 50% stake, will run the new ...

more

Exponential growth in sample volumes pushes biobanks toward

04-01-2013

Every year, nearly 100 million samples are added to biobanks worldwide. Over 1500 bio repositories exist today and efforts are underway to automate the various sample handling and compound storage processes involved in biobanking. The increased focus on preservation of sample integrity and ...

more

Supports growth of Indian pharmaceutical industry

11-10-2012

BASF will launch a production line for precious metal-based fine chemical catalysts at the company’s manufacturing site in Mangalore, India. These catalysts are important for the efficient production of active pharmaceutical ingredients.Start-up of the new production line is slated for the ...

more

03-05-2012

Abbott announced plans to establish its first nutrition research and development center in the country in collaboration with Syngene. The Abbott Nutrition R&D Center in India will focus on the development of science-based, affordable nutrition products for the country and enable the expansion ...

more

Portfolio includes rights to florbetaben, which is in the final stages of its Phase III clinical trials.

18-04-2012

Piramal Healthcare Limited announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG through its newly created subsidiary - Piramal Imaging SA. The portfolio includes rights to florbetaben, which is in ...

more

01-02-2012

Novozymes announced an exploratory research agreement with Sea6 Energy, an India-based company, to jointly develop a process for the production of biofuels from seaweed. The research alliance will use enzymes to convert seaweed-based carbohydrates to sugar, which can then be fermented to ...

more

24-10-2011

The sixth analytica Anacon India, which was held at the Bombay Exhibition Centre (BEC) in India, came to a close with positive results. A total of 182 exhibitors from 18 countries presented their marketable products and new technologies. A total of around 3,000 visitors were primarily ...

more

18-10-2011

DIA announces the appointment of Kaushik Desai as Director of DIA India. Kaushik brings to DIA both a deep knowledge of the global regulatory framework and the pharmaceutical environment in India as well as a passion for the vision and mission of the association. Kaushik is a trained ...

more